◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
奥精医疗 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
+Revenue 206.0M 226.0M 245.0M 236.0M 184.0M 169.0M 124.0M 91.4M
Revenue Growth % -8.8% -7.8% 3.8% 28.3% 8.9% 36.3% 35.7% --
Total Revenue 206.0M 226.0M 245.0M 236.0M 184.0M 169.0M 124.0M 91.4M
Cost Of Revenue 59.6M 39.2M 40.8M 34.6M 29.8M 28.9M 20.8M 18.6M
+Gross Profit 146.4M 186.8M 204.2M 201.4M 154.2M 140.1M 103.2M 72.8M
Gross Margin % 71.1% 82.6% 83.4% 85.3% 83.8% 82.9% 83.2% 79.7%
Total Operating Cost 234.0M 212.0M 168.0M 125.0M 89.6M 107.0M 96.8M 65.4M
Selling Expenses 48.0M 37.7M 31.3M 23.1M 11.5M 15.6M 13.3M 9.4M
Admin Expenses 75.6M 84.3M 38.7M 30.3M 28.2M 38.1M 43.2M 23.7M
Rd Expenses 38.8M 45.5M 57.5M 33.2M 16.0M 22.5M 18.0M 12.4M
Finance Expenses -388,200 -116,900 -3.7M -834,400 1.6M 594,500 -56,000 229,100
+Operating Income -7.4M 49.0M 96.3M 135.0M 102.0M 74.4M 34.8M 27.5M
Operating Margin % -3.6% 21.7% 39.3% 57.2% 55.4% 44.1% 28.1% 30.1%
Non Operating Income 84,800 193,300 -- 139,100 53,700 135,200 200.00 --
Non Operating Expenses 1.7M 93,100 114,800 3.0M 164,100 30,600 549,500 --
Investment Income 11.6M 2.9M 29,900 532,600 2.0M 523,800 1.5M 565,300
Fair Value Change Income 6.4M 15.1M 10.2M 14.4M 2.5M 12.2M -- --
Asset Disposal Income 637,400 -588,900 -324,400 -- -76,600 -- -- --
Asset Impairment Loss -201,300 -- 13,900 1.1M 199,100 427,300 562,300 636,700
Other Income 2.2M 17.0M 8.8M 9.0M 3.5M 260,700 6.4M 907,000
Income Before Tax -8.9M 49.1M 96.2M 132.0M 102.0M 74.6M 34.3M 27.5M
Income Tax 8.2M -3.9M 4.5M 14.0M 15.0M 10.4M 6.7M 3.9M
+Net Income -17.1M 53.0M 91.7M 118.0M 87.1M 64.2M 27.5M 23.5M
Net Margin % -8.3% 23.4% 37.4% 50.0% 47.3% 38.0% 22.2% 25.8%
Net Income Attributable -12.7M 54.2M 95.2M 121.0M 88.9M 67.8M 33.0M 23.5M
Minority Interest -4.5M -1.3M -3.5M -2.7M -1.8M -3.6M -5.5M --
Eps Basic -0.09 0.41 0.71 1.01 0.89 0.68 0.34 0.29
Eps Diluted -0.09 0.41 0.71 1.01 0.89 0.68 0.34 0.29
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
Cash And Equivalents 157.0M 161.0M 260.0M 411.0M 21.1M 75.4M 86.2M 13.0M
Trading Financial Assets 896.0M 902.0M 816.0M 654.0M 471.0M 379.0M -- --
Accounts Receivable 67.2M 59.3M 38.9M 27.8M 18.6M 13.6M 23.7M 17.9M
Notes And Accounts Receivable 67.2M 59.3M 38.9M 27.8M 18.6M 13.6M 23.7M 17.9M
Prepayments 8.2M 7.7M 5.1M 4.1M 4.2M 2.3M 1.5M 5.0M
Inventory 54.6M 32.7M 18.3M 19.0M 21.9M 7.5M 12.5M 15.5M
Total Current Assets 1.2B 1.2B 1.1B 1.1B 554.0M 489.0M 371.0M 258.0M
Fixed Assets -- 182.0M 166.0M 107.0M 66.7M 70.2M 78.2M 12.4M
Fixed Assets Total 174.0M 182.0M 166.0M 107.0M 66.7M 70.2M 78.2M 12.4M
Construction In Progress -- 332,900 1.5M 60.8M 139.0M 123.0M 41.7M 30.2M
Construction In Progress Total 73,100 332,900 1.5M 60.8M 139.0M 123.0M 41.7M 30.2M
Intangible Assets 25.4M 22.1M 23.4M 24.6M 25.8M 27.0M 28.3M 7.1M
Long Term Deferred Expenses 35.5M 34.7M 21.6M 4.3M 6.3M 1.1M 2.2M 4.1M
Total Non Current Assets 343.0M 326.0M 317.0M 305.0M 250.0M 227.0M 154.0M 62.4M
Total Assets 1.5B 1.5B 1.5B 1.4B 805.0M 716.0M 525.0M 320.0M
Accounts Payable 13.0M 10.4M 7.4M 3.3M 1.1M 4.8M 6.4M 12,600
Advance Receipts -- -- -- -- -- 1.4M 1.2M 669,200
Contract Liabilities 5.1M 10.2M 4.0M 2.9M 1.2M -- -- --
Total Current Liabilities 52.3M 50.8M 48.5M 55.2M 71.4M 86.0M 61.7M 8.3M
Long Term Borrowings 40.8M 45.4M 45.9M 56.5M 49.5M 43.8M -- --
Total Non Current Liabilities 66.9M 71.8M 85.0M 100.0M 81.9M 66.3M 11.7M --
Total Liabilities 119.0M 123.0M 133.0M 155.0M 153.0M 152.0M 73.4M 8.3M
Paid In Capital 136.0M 133.0M 133.0M 133.0M 100.0M 100.0M 26.5M 25.7M
Capital Reserve 967.0M 927.0M 888.0M 888.0M 420.0M 420.0M 391.0M 299.0M
Surplus Reserve 46.9M 45.8M 42.4M 31.8M 18.8M 8.4M 4.2M --
Retained Earnings 254.0M 276.0M 239.0M 191.0M 83.1M 4.6M 16.1M -12.7M
Minority Equity 17.1M 21.6M 22.8M 26.3M 29.0M 30.8M 13.2M --
Equity Attributable 1.4B 1.4B 1.3B 1.2B 623.0M 533.0M 438.0M 312.0M
Total Equity 1.4B 1.4B 1.3B 1.3B 652.0M 564.0M 452.0M 312.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
Cash From Sales 192.0M 211.0M 239.0M 239.0M 184.0M 183.0M 122.0M 83.6M
Tax Refunds Received -- 2.3M 5.1M 15.0M 1.8M 206,600 -- --
Total Operating Cash Inflow 197.0M 227.0M 258.0M 276.0M 214.0M 198.0M 143.0M 97.8M
Cash Paid For Goods 72.9M 63.0M 40.2M 33.7M 40.8M 27.4M 3.9M 10.8M
Cash Paid To Employees 66.6M 53.9M 48.0M 44.0M 32.8M 33.9M 24.9M 15.1M
Taxes Paid 22.9M 18.8M 15.7M 35.5M 17.9M 16.9M 11.2M 6.1M
Total Operating Cash Outflow 217.0M 175.0M 156.0M 147.0M 129.0M 110.0M 63.3M 64.7M
Operating Cash Flow -19.6M 51.7M 102.0M 130.0M 84.9M 88.4M 79.7M 33.2M
Total Investing Cash Inflow 994.0M 31.9M 16.0M 35.7M 391.0M 15.6M 111.0M 34.6M
Total Investing Cash Outflow 980.0M 150.0M 213.0M 265.0M 535.0M 222.0M 212.0M 258.0M
Investing Cash Flow 14.2M -118.0M -197.0M -229.0M -143.0M -206.0M -101.0M -223.0M
Cash From Borrowings -- 25.0M -- 47.6M 8.2M 76.7M -- 8.6M
Dividends And Interest Paid 10.8M 17.1M 40.1M 1.2M 1.4M 1.7M -- 310,600
Debt Repayments 10.0M 32.0M 8.6M 34.6M 2.6M 10.3M -- 8.6M
Total Financing Cash Inflow 22.5M 25.0M -- 556.0M 8.2M 119.0M 94.0M 189.0M
Total Financing Cash Outflow 21.5M 57.2M 55.8M 65.7M 4.0M 12.3M -- 8.9M
Financing Cash Flow 1.1M -32.2M -55.8M 490.0M 4.2M 107.0M 94.0M 180.0M
Net Change In Cash -4.5M -98.6M -151.0M 390.0M -54.3M -10.8M 72.9M -10.3M
Ending Cash Balance 157.0M 161.0M 260.0M 411.0M 20.8M 75.1M 85.9M 13.0M
Capex 13.4M 21.9M 45.4M 61.2M 56.4M 77.1M 99.5M 30.6M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...